{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:02:27Z","timestamp":1793152947736,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.autrev.2022.103084","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T22:36:07Z","timestamp":1648161367000},"page":"103084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"21","author":[{"given":"Hui","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103084_bb0005","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/rheumatology\/key329","article-title":"Comorbidities (excluding lymphoma) in Sj\u00f6gren's syndrome","volume":"60","author":"Pego-Reigosa","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103084_bb0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5114\/reum.2017.68913","article-title":"Is primary Sj\u00f6gren's syndrome a risk factor for malignancies different from lymphomas? What does the literature highlight about it?","volume":"55","author":"Manzo","year":"2017","journal-title":"Reumatologia"},{"key":"10.1016\/j.autrev.2022.103084_bb0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sjogren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103084_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.autrev.2022.103084_bb0025","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.autrev.2022.103084_bb0030","article-title":"Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103084_bb0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3899\/jrheum.191027","article-title":"Bidirectional relationship between primary Sj\u00f6gren syndrome and non-Hodgkin lymphoma: a nationwide Taiwanese population-based study","volume":"47","author":"Wang","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103084_bb0040","doi-asserted-by":"crossref","first-page":"50098","DOI":"10.18632\/oncotarget.15100","article-title":"Predictable biomarkers of developing lymphoma in patients with Sj\u00f6gren syndrome: a nationwide population-based cohort study","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2022.103084_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","article-title":"Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren\u2019s syndrome in Taiwan","volume":"71","author":"Weng","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103084_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.autrev.2022.103084_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-5-59","article-title":"Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma","volume":"5","author":"Hemminki","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.autrev.2022.103084_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/annonc\/mdr333","article-title":"Autoimmune disease and subsequent digestive tract cancer by histology","volume":"23","author":"Hemminki","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.autrev.2022.103084_bb0065","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/annonc\/mdu144","article-title":"Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.autrev.2022.103084_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.11.007","article-title":"Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease","volume":"12","author":"Castro","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.autrev.2022.103084_bb0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/acr.21887","article-title":"Risk of non-Hodgkin\u2019s lymphoma in primary Sj\u00f6gren\u2019s syndrome: a population-based study","volume":"65","author":"Johnsen","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.autrev.2022.103084_bb0080","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sjogren\u2019s syndrome","volume":"45","author":"Lazarus","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103084_bb0085","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 126","key":"10.1016\/j.autrev.2022.103084_bb0090","first-page":"40","article-title":"Risk of non-Hodgkin\u2019s lymphoma and thyroid cancer in primary Sj\u00f6gren\u2019s syndrome measured using the Korean health insurance claims database","volume":"38","author":"Ahn","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103084_bb0095","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/1756-185X.13927","article-title":"Risk of malignancy in Korean patients with primary Sj\u00f6gren's syndrome","volume":"23","author":"Kang","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103084_bb0100","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00296-019-04433-2","article-title":"Incidence of cancer in a cohort of patients with primary Sj\u00f6gren syndrome in Argentina","volume":"39","author":"Brom","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.autrev.2022.103084_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.autrev.2022.103084_bb0110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bjh.12330","article-title":"Subsequent leukaemia in autoimmune disease patients","volume":"161","author":"Hemminki","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.autrev.2022.103084_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103084_bb0120","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cncr.25524","article-title":"Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans","volume":"117","author":"Landgren","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2022.103084_bb0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2010.30.1515","article-title":"Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin\u2019s lymphoma in veterans from the United States","volume":"29","author":"Koshiol","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.autrev.2022.103084_bb0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","article-title":"Incidence of malignancy in primary Sjogren\u2019s syndrome in a Chinese cohort","volume":"49","author":"Zhang","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103084_bb0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ijc.25080","article-title":"Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005","volume":"127","author":"Sunesen","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.autrev.2022.103084_bb0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103084_bb0145","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A longitudinal cohort study of Finnish patients with primary Sj\u00f6gren\u2019s syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103084_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.autrev.2022.103084_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sj\u00f6gren\u2019s syndrome in the north east of England: a long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103084_bb0160","first-page":"2376","article-title":"Differential risk of non-Hodgkin\u2019s lymphoma in Italian patients with primary Sj\u00f6gren\u2019s syndrome","volume":"24","author":"Valesini","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103084_bb0165","first-page":"201","article-title":"Elevated incidence of hematologic malignancies in patients with Sj\u00f6gren\u2019s syndrome compared with patients with rheumatoid arthritis (Finland)","volume":"8","author":"Kauppi","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.autrev.2022.103084_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.autrev.2022.103084_bb0175","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(88)80259-4","article-title":"Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis","volume":"19","author":"Hyjek","year":"1988","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.autrev.2022.103084_bb0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2022.103084_bb0185","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0046-8177(85)80155-6","article-title":"Follicular bronchitis\/bronchiolitis","volume":"16","author":"Yousem","year":"1985","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.autrev.2022.103084_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005792-200003000-00004","article-title":"Thyroid disease in primary Sj\u00f6gren syndrome. Study in a series of 160 patients","volume":"79","author":"Ramos-Casals","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103084_bb0195","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/js.2018-00427","article-title":"The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer","volume":"3","author":"Silva de Morais","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.autrev.2022.103084_bb0200","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s12253-019-00580-w","article-title":"Thyroid carcinoma coexisting with Hashimoto\u2019s Thyreoiditis: clinicopathological and molecular characteristics clue up pathogenesis","volume":"25","author":"Moln\u00e1r","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.autrev.2022.103084_bb0205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.14639\/0392-100X-1709","article-title":"Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients","volume":"37","author":"Liang","year":"2017","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"10.1016\/j.autrev.2022.103084_bb0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sj\u00f6gren\u2019s syndrome","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103084_bb0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.14-2-157","article-title":"A retrospective study of long-term outcomes in 152 patients with primary Sjogren\u2019s syndrome: 25-year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.autrev.2022.103084_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1573395511309010003","article-title":"Possible mechanisms of lymphoma development in Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Dong","year":"2013","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.autrev.2022.103084_bb0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1055-9965.EPI-13-0695","article-title":"Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review","volume":"23","author":"McShane","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.autrev.2022.103084_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02284066","article-title":"Chronic myelomonocytic leukemia and primary Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Ponge","year":"1988","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103084_bb0235","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.semarthrit.2005.07.001","article-title":"Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren\u2019s syndrome-an important but under-recognized association","volume":"35","author":"Friedman","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103084_bb0240","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch. Intern. Med."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:24Z","timestamp":1761600444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1568997222000544"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103084","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103084"}}